Insights
FUGO Precision 3D Integrates Graphy Materials for High-Precision Dental Manufacturing
FUGO Precision 3D, a developer of 3D printing technology for dental manufacturing, has announced a strategic collaboration with South Korea’s Graphy, a developer of photopolymer materials for 3D printing, ahead of its official market debut at LMT Lab Day 2026 in Chicago. The partnership will integrate Graphy’s advanced photopolymer materials into FUGO’s centrifugal 3D printing platform, creating a streamlined, high-precision workflow for dental applications.
News
Follow us on Social Media
Popular Posts
Category
We realize your creation
FacFox provides one-stop solution with comprehensive on-demand manufacturing capabilities and data-driven analysing technologies, see our available service, feel free to reach us to realize your creation!
Most Viewed
This Iron Man Suit Exists in Real Life and Can Fly
Unless they are really into cosplay, building an Iron Man suit really isn’t at the top of most people’s bucket list. I mean, after all, they only need to go buy a costume, or have on made. But for Ada ...
CRP Group supports Energica in wake of fire at MotoE circuit Additive Manufacturing
It’s been a tough week for the Energica Motor Company and the rest of the MotoE community, after a fire at a paddock at the Circuito de Jerez in Spain on March 14th destroyed the majority of the motorcycles and equipment inside.
IKEA’s former head of design Marcus Engman joins UNYQ team AM Industry
UNYQ, a company specializing in custom 3D printed medical devices and wearables, announced that it has appointed the former Head of Design at IKEA, Marcus Engman, as its new Vice President of Design. Engman served as IKEA’s Head of Design for six years; he left in September 2018 to found his own design consultancy business.
On the precipice of expansion: a conversation with LOOP 3D Decision Makers
LOOP 3D is a 3D printer manufacturer based in Ankara, Turkey, which brought to market the LOOP PRO extrusion-based 3D printing system late last year. The young company is now preparing to expand into the European market with the opening of an office in Wroclaw, Poland. At this pivotal time of growth for the company, we caught up with Mehmet Erkan Ustaoğlu, Founder and CEO of LOOP 3D, and Anna Bogusz, EMEA Sales Manager of LOOP 3D.
The 3D Ecosystem Converges with Sketchfab CEO Alban Denoyel
The present and the future are in 3D, according to Sketchfab co-founder and CEO Alban Denoyel. The reason for this is that the physical world itself is in 3D and, as more technologies open up more wa ...
Goodbye Airbus A380, one of the first planes to fly 3D printed parts Aerospace
Airbus will stop production of its giant Airbus A380 models due to low demand for the huge and hugely expensive aircraft. This is not something directly related to 3D printing but it does affect the AM industry indirectly as Airbus is Europe’s largest user of AM technologies and the A380 did feature a number of 3D printed parts.
Made In Space’s VULCAN to be further developed under new NASA contract Aerospace
As additive manufacturing technologies continue to evolve here on Earth, they are also moving steadily ahead in outer space, due in large part to American company Made In Space. The company, which in 2016 sent the first 3D printer into space to be used aboard the International Space Station (ISS), has now won a contract from NASA to continue developing VULCAN, its next-generation metal space manufacturing system.
DDD Focuses on Healthcare after Solid-Organ Scaffolds’ Success
3D Systems significantly expanded its focus on regenerative medicine and bioprinting solutions after reducing its workforce to concentrate on the healthcare AM sector. The expanded focus follows on great progress made in the development of 3D printing systems for solid-organ scaffolds. This progress is the product of collaboration between 3D Systems, United Therapeutics Corporation and UTC’s organ manufacturing and transplantation-focused subsidiary, Lung Biotechnology PBC. 3D Systems intends to leverage this work and accomplishments with other partners to invest, further develop and commercialize solutions for regenerative medicine. Applications of its R&D program include the development of non-solid organ applications requiring biologically sustainable vasculature.
